The GO-Bio initial conceptual stage program provides funding for a one-year conceptual phase. During this period, research teams refine their exploitation ideas and conduct market analyses as well as freedom-to-operate (FtO) assessments. The goal is to evaluate the commercial potential and legal feasibility of the proposed innovations.

In Phase 5, several projects have been selected across different areas of biotechnology and healthcare. The list below includes the project titles. Additional detailed information on each project is available in the downloadable PDF document linked on this page.

Selected Projects in Conceptual Stage Phase 5

• ACMS4Patients: Magnetic Field Therapy for ALS
• BINKOM: Targeting Chronic Joint Diseases Through Innovative Connective Tissue Therapy
• BIONIS: Early Detection of Acute Kidney Injury Through Innovative Biomarker Diagnostics
• CARE: Fast-Acting Antidepressant Inspired by Caffeine’s Mechanism
• CervixTEST: A Novel Molecular RNA-Based Diagnostic for Accurate Cervical Cancer Screening
• CHITOX: Bacterial Toxins as a New Weapon Against Blood Cancer
• Coldex: Broad-Spectrum Defence Against Respiratory Viruses
• Cure4HAIR: Tackling Alopecia Areata with Precision Therapy
• Deep-DERM: Revolutionising Skin Diagnostics with AI
• eCAR: Next-Generation CAR Therapy with Enhanced Precision and Safety
• EpiTher: Breaking Drug Resistance in Epilepsy
• GestaltMatcher: AI-Powered Facial Analysis to Accelerate Rare Disease Diagnosis
• InnoZell: Faster, Safer, Animal-Free Pyrogen Testing
• INTERDEL: Surfactant Carriers to Revolutionise Drug Delivery in the Deep Lung
• KardioDetekt: Sweat-Based Wearable for Early Detection of Cardiovascular Diseases
• MATRIXCURE: Pioneering a Broad-Spectrum Drug Against Ebola Virus
• Medical-Lace: Customised Textile Implants with Biomechanical Precision
• MOMAC: Measuring Biological Age to Accelerate Longevity Research
• Mykopoint: Rapid and Precise Therapy for Life-Threatening Fungal Infections
• NEUROLITH: Hope for Spinal Cord Injury Patients through 3D-Printed Implants
• NTSC: New Antibiotics Against Resistant Gonorrhoea
• OptoVAX: Light-Controlled Live Vaccines to Combat Parasitic Infections
• ORCA: Next-Generation Microphysiological System for Animal-Free Research
• PearNet: Smart Sensor Network for Epilepsy Detection and Management
• PEDRA: Tailor-Made Cancer Therapy Through Functional Precision Testing
• PRISTINE: A New Era in IgE-Based Diagnostics for Parasitic Infections
• proP: Novel mRNA Therapy to Treat Type 2 Diabetes and Prevent Organ Damage
• Propha: Customised Phage Therapy to Reduce Antibiotic Use in Poultry Farming
• QTAS: Revolutionising Cancer Therapy Monitoring with Quantum Sensor Technology
• ReRetina: A Breakthrough in Producing Human Photoreceptors to Combat Vision Loss
• REST: Rapid, Reliable, and Equipment-Free Infectious Disease Testing
• SWIBRiD: New Diagnostics for Immune Disorders and Hereditary Cancer
• SynFET: Next-Gen Biosensors for Early Stroke Detection
• SynVec: Affordable, Synthetic DNA Vectors for Personalized Gene Therapy
• TargetBio: AI-Powered Precision for Safer CAR-T Cell Therapies
• TASI: Targeted Intracellular Antibodies for Selective ADP-Ribosylation Inhibition
• TransfektionsAdditiv: Unlocking the Full Potential of Gene Therapy
• VaPoC-Seq: Automated Point-of-Care Sequencing for Everyday Clinical Use
• XRmicroscopy: Software tools for interactive 3D real-time interaction with biological samples under the microscope using virtual and augmented reality
• Kryo-ET: Revolutionising Cryo-ET: Faster, Smarter Structural Insights